Sponsor or institution
Clinical trials and research at Rock Immune, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $648,336 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Bivalent CD47 Immunotoxin for Targeted Therapy of T-ALL in kids
A new targeted therapy using a two-part CD47-directed toxin is being studied for children with T-cell acute lymphoblastic leukemia who have limited treatment options.
-
Targeted therapy for skin lymphoma using a new immunotoxin
This study is testing a new treatment for cutaneous T-cell lymphoma (CTCL) that uses a special therapy to help your immune system fight the cancer more effectively, and it could be a great option for patients whose CTCL hasn't responded to other treatments.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.